Brett M. Hickman - 28 Apr 2022 Form 3 Insider Report for ModivCare Inc (MODV)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
09 May 2022, 17:16:52 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan B. Bush by Power of Attorney

Key filing fact

Brett M. Hickman filed Form 3 for ModivCare Inc (MODV) on 09 May 2022.

Key facts

  • This page summarizes Brett M. Hickman's Form 3 filing for ModivCare Inc (MODV).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 May 2022, 17:16.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MODV holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,750
Date
28 Apr 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODV holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,013
Exercise price
$114.24
Footnotes
F2
MODV holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
28 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,501
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units scheduled to vest as follows: (1) 583 shares will vest on April 18, 2023, (2) 584 shares will vest on April 18, 2024 and (3) 583 shares will vest on April 18, 2025, in each case, subject to the reporting person's continued employment.

Footnote F2

Option becomes exercisable with respect to: (1) 1,671 shares on April 18, 2023, (2) 1,671 shares on April 18, 2024 and (3) 1,671 shares on April 18, 2025, in each case, subject to the reporting person's continued employment.

Footnote F3

Represents the contingent right to receive at the expiration of a three-year vesting period beginning on the April 18, 2022 grant date a number of shares of issuer common stock determined by multiplying the number of performance units by a percentage from 50% to 200% that corresponds to specified share price thresholds measured by reference to a volume-weighted average price (VWAP) of the issuer's common stock over a specified period of trading days achieved at any time during the vesting period of the award, subject to the reporting person's continued employment throughout the vesting period. The number of shares of common stock reported assumes a VWAP performance target achieved that corresponds to a 100% payout level. Vested shares of common stock, if any, are to be delivered within ten business days following the expiration of the vesting period.

SEC remarks

Exhibit Index: Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .